Hong Kong Exchanges and Clearing Limited

Hong Kong Exchanges and Clearing Limited is one of the world’s major exchange groups, and operates a range of equity, commodity, fixed income and currency markets.
See below for the Latest Hong Kong Exchanges and Clearing Limited News, Analysis, Profit Results, Share Price Information, and Commentary.

HKEX rolls out new investor relations portal

This will allow listed issuers to connect with their stakeholders.

HKEX rolls out new investor relations portal

This will allow listed issuers to connect with their stakeholders.

ETF trading under Stock Connect kicks off

There are over 130 EFTs listed in Hong Kong.

HKEX to attract high-quality US-listed Chinese firms: PwC

Overall market capitalisation in Hong Kong reached $42t in 2021.

HK’s IPO market sees slowdown in H122

Funds raised in H122 plummeted by 92% YoY. 

After 25 years, has Hong Kong’s capital markets lost its sparkle?

Funds raised by IPOs in H122 are predicted to reach HK$17.1 b, a 92% decrease from 2021.

Lam OKs reappointment of Laura Cha as HKEX head

Cha was elected during a board meeting on 27 April.

HKEX lists first MSCI China A 50 Connect Index ETFs

A total of three EFTs listed on the bourse.

HKEX mulls establishment of New York office

The office is expected to open as early as 2022.

HKEX profit declines anew, falling ​​to HK$3.3 billion in Q3

The bourse’s income was dragged down by the delay in potential billion-dollar IPOs.

HKEX enters China's derivatives market with A-share futures launch

The bourse’s new futures contract is based on the MSCI China A 50 Connect Index.

How HKEX's A-share futures launch will shake up Singapore’s monopoly in China

SGX shares already slumped 4% when HK announced the futures’ launch on 23 August.

HK cancels Wednesday stock trading due to Typhoon Kompasu

The Hong Kong-China stock connect and derivatives markets were also halted.

HKEX proposes prudent approach on SPAC listings

The public consultation will end on 31 October.

China and HK IPO market forecast in Q4 positive: Deloitte

HK remains a preferred overseas listing destination for Chinese companies.

HKEX, HKSTP partner to beef up biotech, fintech initiatives

The MoU is intended to enhance Hong Kong’s standing as a biotech funding hub.